Regdanvimab for patients with mild-to-moderate COVID-19: a retrospective cohort study and subgroup analysis of patients with the Delta variant

Regdanvimab for patients with mild-to-moderate COVID-19: a retrospective cohort study and subgroup analysis of patients with the Delta variant
Jang et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2022.12.035
https://c19early.org/jang4.html